The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
Reasoning
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
Cite this ruling
CBP Ruling K83806 (3004909120): The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Herp-ezy Lip Balm from England
The tariff classification of Dermac Spray, Neuroskin Spray Forte and Neuroskin Spray Mild, put up in 50ml pump-spray bottles, from Ireland
The tariff classification of Requip (Ropinirole hydrochloride) tablets from the United Kingdom
The tariff classification of BURNAID Burn First Aid Dressings; BURNAID Burn First Aid Burn Gel; Rapaid First Aid Cream; Rapaid First Aid Spray; and Rapaid Everyday Powder, from Australia
The tariff classification of BURNAID Burn First Aid Dressings; BURNAID Burn First Aid Burn Gel; Rapaid First Aid Cream; Rapaid First Aid Spray; and Rapaid Everyday Powder, from Australia